Lv11
40 积分 2023-05-17 加入
14-day versus 28-day trifluridine–tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan
7分钟前
待确认
Malignant pleural effusion due to angiosarcoma
11个月前
已关闭
Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel
1年前
已完结